Business Description
Takeda Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : US8740602052
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.73 | |||||
Debt-to-EBITDA | 4.09 | |||||
Interest Coverage | 3.36 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.12 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.9 | |||||
3-Year EBITDA Growth Rate | -5.3 | |||||
3-Year EPS without NRI Growth Rate | -8 | |||||
3-Year FCF Growth Rate | -32.8 | |||||
3-Year Book Growth Rate | 11.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.43 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.49 | |||||
9-Day RSI | 61.75 | |||||
14-Day RSI | 76.06 | |||||
6-1 Month Momentum % | 19.73 | |||||
12-1 Month Momentum % | 20.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.28 | |||||
Quick Ratio | 0.77 | |||||
Cash Ratio | 0.38 | |||||
Days Inventory | 284.69 | |||||
Days Sales Outstanding | 58.55 | |||||
Days Payable | 99.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.15 | |||||
Dividend Payout Ratio | 0.44 | |||||
3-Year Dividend Growth Rate | 1.5 | |||||
Forward Dividend Yield % | 4.62 | |||||
5-Year Yield-on-Cost % | 4.28 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -2.65 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 66.05 | |||||
Operating Margin % | 10.46 | |||||
Net Margin % | 6.38 | |||||
FCF Margin % | 11.23 | |||||
ROE % | 4.05 | |||||
ROA % | 1.93 | |||||
ROIC % | 3.64 | |||||
ROC (Joel Greenblatt) % | 19.39 | |||||
ROCE % | 3.25 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.95 | |||||
Forward PE Ratio | 35.59 | |||||
PE Ratio without NRI | 22.95 | |||||
Shiller PE Ratio | 31.47 | |||||
Price-to-Owner-Earnings | 14.79 | |||||
PEG Ratio | 2.67 | |||||
PS Ratio | 1.47 | |||||
PB Ratio | 0.96 | |||||
Price-to-Free-Cash-Flow | 13.27 | |||||
Price-to-Operating-Cash-Flow | 7.63 | |||||
EV-to-EBIT | 26.15 | |||||
EV-to-Forward-EBIT | 25.09 | |||||
EV-to-EBITDA | 8.7 | |||||
EV-to-Forward-EBITDA | 9.81 | |||||
EV-to-Revenue | 2.37 | |||||
EV-to-Forward-Revenue | 2.42 | |||||
EV-to-FCF | 21.33 | |||||
Price-to-Projected-FCF | 0.59 | |||||
Price-to-Median-PS-Value | 0.78 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.29 | |||||
Earnings Yield (Greenblatt) % | 3.82 | |||||
FCF Yield % | 7.62 | |||||
Forward Rate of Return (Yacktman) % | 18.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Takeda Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 550,753.157 | ||
EPS (TTM) (MXN) | 11.253 | ||
Beta | -0.03 | ||
Volatility % | 20.62 | ||
14-Day RSI | 76.06 | ||
14-Day ATR (MXN) | 0.027016 | ||
20-Day SMA (MXN) | 287.95 | ||
12-1 Month Momentum % | 20.13 | ||
52-Week Range (MXN) | 231.51 - 293.2 | ||
Shares Outstanding (Mil) | 3,170.36 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Takeda Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Takeda Pharmaceutical Co Ltd Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Takeda Pharmaceutical Co Ltd Frequently Asked Questions
What is Takeda Pharmaceutical Co Ltd(MEX:TAK)'s stock price today?
When is next earnings date of Takeda Pharmaceutical Co Ltd(MEX:TAK)?
Does Takeda Pharmaceutical Co Ltd(MEX:TAK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |